S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer

Abstract

S100A16 is a member of the S100 calcium-binding protein family. It is overexpressed in many types of tumors and associated with proliferation, migration, and invasion; however, its function in human prostate cancer is unresolved. Our objective was to determine its effects and the underlying pathways of S100A16 in prostate cancer tissues and cells. We measured S100A16 expression by quantitative real-time polymerase and Western blotting in eight matched prostate cancer and adjacent normal tissues, and in three prostate cancer cell lines, DU-145, LNCaP, and PC-3, compared to a normal prostate epithelial cell line PrEC. DU-145 cells stably overexpressing S100A16 and PC-3 cells with S100A16 knockdown were established by transfection with S100A16 overexpression plasmid or shRNAs. Invasion, migration, and proliferation were analyzed by transwell assay, wound healing, and colony formation assays, respectively. Western blotting and invasion assays were performed to determine expressions and activation of AKT, ERK, p21, and p27. S100A16 was significantly overexpressed in both prostate cancer tissues and cells lines compared to normal controls (P < 0.05). Overexpression of S100A16 significantly promoted invasion, migration, and proliferation in prostate cancer cells in vitro, whereas silencing S100A16 showed the converse effects (P < 0.05). Furthermore, overexpression of S100A16 activated cell signaling proteins AKT and ERK and downregulated tumor suppressors p21 and p27. Specific inhibitors, LY294002 and PD98059, suppressed activation of AKT and ERK, which attenuated DU-145 cell clone formation and invasion induced by S100A16 overexpression. S100A16 may promote human prostate cancer progression via signaling pathways involving AKT, ERK, p21, and p27 downstream effectors. Our findings suggest that S100A16 may serve as a novel therapeutic or diagnostic target in human prostate cancer.

Inhibition of H3K27me3 Histone Demethylase Activity Prevents the Proliferative Regeneration of Zebrafish Lateral Line Neuromasts

“…We observed that inhibition of ERK activation by U0126 increased the expression of p21 and p27 mRNA levels, suggesting that a decrease in p-ERK seems to be involved in the alteration of p21 and p27 mRNA expression during hair cell regeneration. These results are consistent with previous data showing that ERK activity contributes to the down-regulation of p21 and p27 that precedes cell cycle progression (Kortylewski et al, 2001; Villanueva et al, 2007; Hwang et al, 2009; Zhu et al, 2016; Seo et al, 2017). The possibility that other signaling pathways are involved in controlling p21 and p27 during hair cell regeneration cannot be excluded from our results.…”

Retrospective Proteomic Screening of 100 Breast Cancer Tissues

“…This member of the S100 protein family has been reported to be involved and overexpressed in several pathological affections, including cancer, but with different and often contradictory roles [119][120][121]. In our tumor tissues we found a single form of S10AG with a 3x fold increase versus the normal tissues.…”

Nobiletin, a citrus polymethoxyflavone, enhances the effects of bicalutamide on prostate cancer cellsviadown regulation of NF-κB, STAT3, and ERK activation

“…In addition, ERK is associated with the proliferation of cancer cells and tumor invasion via degradation of extracellular matrix proteins. 42 Review studies documented the ERK can activate transcription factors, such as c-myc and NF-kB. 43 This makes ERK1/2 an important anti-prostate cancer target.…”